Programma

Hieronder vind je het volledige programma van het 27e Nationale Longkankersymposium 2026. Klik op de verschillende presentaties om meer achter de sprekers te weten te komen.

Session 4 || Sushil Badrising & Sjaak Burgers/Frank Borm

Coffee break

Tijd: 10:45 - 11:28

Antibody Drug Conjugates

Tijd: 15:55 - 16:20

How to navigate through the first line treatment options of EGFRm positive NSCLC

Tijd: 14:40 - 15:05

Multiple new drugs have been introduced in the recent years for EGFR mutation positive NSCLC, both in first as well as later lines. Choosing the first line regimen has consequences for later line options. In this presentation we will discuss how to navigate through the field of these innovations.

A multidisciplinary approach to stem cell therapy for airway fistulas

Tijd: 14:15 - 14:40

Lung Cancer from an evolutionary perspective: therapeutic consequences. TRACERx study

Tijd: 13:45 - 14:15

Vera Bonta Award 2026

Tijd: 13:30 - 13:43

Screening without losing; use of risk models in Lung Cancer Screening

Tijd: 11:55 - 12:20

Are biomarkers a useful tool for early detection of lung cancer?

Tijd: 11:30 - 11:55

Optimizing radiotherapy in combination treatment for SCLC

Tijd: 10:20 - 10:45

Klik hier voor een samenvatting

New drugs, new side effects: Cytokine Release Syndrome and other toxicities

Tijd: 09:55 - 10:20

Finally: New treatment options for small cell lung cancer patients

Tijd: 09:30 - 09:55

Session 3 || Moderators: Joop de Langen & Frank Borm

Session 2 || Moderators: Sjaak Burgers & Wieneke Buikhuisen

Session 1 || Moderators: Gerrina Ruiter & Jasper Smit

Welcome

Tijd: 09:25 - 09:26

Coffee served in the conference room

Drinks

Tijd: 16:20 - 17:00

Who can we spare immunotherapy? Biomarkers

Tijd: 16:00 - 16:05

Targeted treatment in early stage NSCLC

Tijd: 15:00 - 15:05

First line options for EGFR+ NSCLC

Tijd: 14:30 - 14:35

Lunch

Tijd: 12:20 - 13:30

What to do with all these data?

Tijd: 10:50 - 10:55

Immunotherapy and comorbidities, the side effect treatment beyond steroids

Tijd: 15:30 - 15:35

”Are you NUTs”? Diagnostical and molecular challenges in squamous cell lung cancer

Tijd: 12:10 - 12:15

Vaping: A lifeline for ‘chain smokers’ or a ‘Trojan horse’? And what is our responsibility?

Tijd: 14:00 - 14:05

Coffee break

Tijd: 15:05 - 15:28

Surgery is key in the treatment of stage III NSCLC. 

Tijd: 10:25 - 10:26

Radiotherapy is key in the treatment of stage III NSCLC

Tijd: 10:00 - 10:05

Neo-adjuvant therapy: lessons from other malignancies (than NSCLC)

Tijd: 11:40 - 11:45

The Legend of the RECIST criteria: Will Artificial Intelligence Take Over Tumor Measurement?

Tijd: 09:30 - 09:35

Registration

Tijd: 09:00 - 09:27